Publications
45
Citations
64
Est. group size
~3
Recurring co-author estimate
Active years
9
Publishing since 2018
Taylor Goodstein's research focuses on urology and urologic oncology, with particular attention to kidney (renal cell), bladder, testicular, and prostate cancers. Work spans clinical prognostic markers, immunotherapy response, surgical outcomes (e.g., urethroplasty, nephrolithotomy, penile implants), and broader patient-care issues like frailty assessment, opioid use, and mental health in cancer survivors. Much of the output is applied clinical research aimed at improving diagnosis, treatment selection, and post-surgical care for urologic conditions.
Publication output was low and sporadic from 2017-2022 but has grown sharply since 2023, peaking at 20 publications in 2025, indicating a recent and substantial increase in research activity.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Artificial-intelligence models vs. radiologists in the detection of clinically significant prostate cancer on mpMRI: a meta-analysis
European Radiology · 2026
- An increase in splenic volume after first-line immunotherapy is associated with worse PFS in patients with metastatic renal cell carcinoma
The Oncologist · 2026
- Does the Veterans Affairs Risk Analysis Index Overestimate Frailty in Patients With Localized Prostate Cancer?
Urology Practice · 2026
- Laboratory paraneoplastic syndrome resolution is associated with reduced recurrence and improved survival in non-metastatic renal cell carcinoma
Urologic Oncology Seminars and Original Investigations · 2026
- IP02-20 IMMUNE MICROENVIRONMENT SIGNATURES OF RESPONSE TO CRETOSTIMOGENE GRENADENOREPVEC IN BCG-UNRESPONSIVE NON–MUSCLE INVASIVE BLADDER CANCER
The Journal of Urology · 2026
- Contemporary Validation of the Renal Cell Carcinoma Inflammatory Score (RISK) for Preoperative Prognostication in Non-Metastatic Renal Cell Carcinoma
Urology Practice · 2026
- A Chance to Heal With Cold Hard Steel
Journal of Clinical Oncology · 2025
- Incidence of New Mental Health Diagnosis in Testicular Cancer Survivors
Urology · 2025
- The prognostic utility of preoperative β2 microglobulin in patients with renal cell carcinoma.
Journal of Clinical Oncology · 2025
- IP25-19 REDUCING HEALTH INEQUITY IN PROSTATE CANCER SCREENING: RESULTS OF AN INSTITUTION-WIDE INTERVENTION AT A SAFETY NET HOSPITAL CARING FOR A HIGH-RISK POPULATION
The Journal of Urology · 2025
- Opioid Use in Patients With Testicular Cancer: Patterns and Risk Factors
Clinical Genitourinary Cancer · 2025
- Preoperative β2 Microglobulin Is a Prognostic Factor in Patients with Renal Cell Carcinoma and Normal Kidney Function
Research and Reports in Urology · 2025
- Editorial Commentary
Urology Practice · 2025
- Early Post-Operative Events After Urethroplasty in Obese Patients: A Multi-Institutional Retrospective Series
Urology · 2024
- (385) Compliance with Post-Vasectomy Semen Analysis (PVSA): A Retrospective Survey Study
The Journal of Sexual Medicine · 2024
- Urologic Oncology Seminars and Original Investigations×5
- Urology×4
- Journal of Clinical Oncology×4
- The Journal of Urology×4
- Current Opinion in Oncology×3
- Megan Hinkley
Medicine · The Ohio State University
- Benjamin N. Schmeusser
Medicine · Indiana University
- Chandru P. Sundaram
Medicine · Indiana University
- Elshad Hasanov
Medicine · The Ohio State University
- Ronald S. Boris
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile